tirzepatide with glycerin Flex-Dose 1 mL Injectable 10 mg/mL Compounded Tirzepatide (GLP-1/GIP)

For more details, See Full Comparison at Sprout Health Weight Loss.com YMYL, FTC, and FDA Compliance Disclaimer This article is provided for informational and educational purposes only

This drug is FDA-approved for weight management in individuals who are obese or overweight with the presence of one weight-related comorbid condition, such as heart disease or hypertension

You should not use Tirzepatide once it has expired, as its stability, potency, purity, and sterility can no longer be trusted

Monitoring and Early Intervention After Discontinuation Track your weight weekly for at least three months after stopping tirzepatide

For most medications, this is unlikely to create clinically significant changes